Research programme: nitric oxide-donating compounds - Ferrer/NicOxAlternative Names: GF-015646-00; GF-015647; NCX 1047
Latest Information Update: 12 Aug 2013
At a glance
- Originator NicOx
- Developer Ferrer; NicOx
- Class Corticosteroids
- Mechanism of Action Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Dermatitis; Psoriasis